NO320104B1 - Fremgangsmate for fremstilling av baccatin i naervaere av et enzym og en acetyldonor, enzymet, fremgangsmate for fremstilling av dette og fremgangsmate for fremstilling av taxol og/eller taxolderivater. - Google Patents
Fremgangsmate for fremstilling av baccatin i naervaere av et enzym og en acetyldonor, enzymet, fremgangsmate for fremstilling av dette og fremgangsmate for fremstilling av taxol og/eller taxolderivater. Download PDFInfo
- Publication number
- NO320104B1 NO320104B1 NO20003787A NO20003787A NO320104B1 NO 320104 B1 NO320104 B1 NO 320104B1 NO 20003787 A NO20003787 A NO 20003787A NO 20003787 A NO20003787 A NO 20003787A NO 320104 B1 NO320104 B1 NO 320104B1
- Authority
- NO
- Norway
- Prior art keywords
- enzyme
- acetyl
- baccatin
- taxol
- coenzyme
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 89
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 89
- 229930190007 Baccatin Natural products 0.000 title claims abstract description 35
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 title claims abstract 7
- 238000000034 method Methods 0.000 title claims description 39
- 229930012538 Paclitaxel Natural products 0.000 title claims description 24
- 229960001592 paclitaxel Drugs 0.000 title claims description 24
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title claims description 24
- 150000004579 taxol derivatives Chemical class 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title description 5
- 102000005421 acetyltransferase Human genes 0.000 claims abstract description 34
- 108020002494 acetyltransferase Proteins 0.000 claims abstract description 34
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims abstract description 8
- 238000004113 cell culture Methods 0.000 claims abstract description 6
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 claims description 94
- 229940100228 acetyl coenzyme a Drugs 0.000 claims description 33
- 238000000746 purification Methods 0.000 claims description 29
- 238000006640 acetylation reaction Methods 0.000 claims description 25
- 230000021736 acetylation Effects 0.000 claims description 23
- 229930004057 10-desacetyltaxuyunnanin C Natural products 0.000 claims description 17
- RAKDXBHPGCOTQG-SFPMZPPXSA-N 10beta-hydroxytaxa-4(20),11-diene-2alpha,5alpha,14beta-triyl triacetate Chemical compound O[C@H]1C[C@]2(C)CC[C@H](OC(C)=O)C(=C)[C@H]2[C@H](OC(C)=O)[C@@H]2[C@@H](OC(=O)C)CC(C)=C1C2(C)C RAKDXBHPGCOTQG-SFPMZPPXSA-N 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- 238000001514 detection method Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- KFFHSFCOKCGBBW-VCPDXWRASA-N taxa-4(20),11-diene-2alpha,5alpha,10beta,14beta-tetrayl tetraacetate Chemical compound CC(=O)O[C@H]1C[C@]2(C)CC[C@H](OC(C)=O)C(=C)[C@H]2[C@H](OC(C)=O)[C@@H]2[C@@H](OC(=O)C)CC(C)=C1C2(C)C KFFHSFCOKCGBBW-VCPDXWRASA-N 0.000 claims description 5
- 229930002202 taxuyunnanin C Natural products 0.000 claims description 5
- 230000032050 esterification Effects 0.000 claims description 3
- 238000005886 esterification reaction Methods 0.000 claims description 3
- 238000002372 labelling Methods 0.000 claims description 3
- 230000002285 radioactive effect Effects 0.000 claims description 3
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 description 57
- 108090000623 proteins and genes Proteins 0.000 description 57
- 230000000694 effects Effects 0.000 description 39
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 34
- 239000000872 buffer Substances 0.000 description 32
- 230000007306 turnover Effects 0.000 description 25
- 239000007983 Tris buffer Substances 0.000 description 23
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 23
- 239000000758 substrate Substances 0.000 description 20
- 235000011187 glycerol Nutrition 0.000 description 17
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 14
- 239000000499 gel Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 238000011534 incubation Methods 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 150000001450 anions Chemical class 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 125000006239 protecting group Chemical group 0.000 description 9
- 238000002523 gelfiltration Methods 0.000 description 8
- 229920002684 Sepharose Polymers 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000003446 ligand Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical group C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 6
- 238000001042 affinity chromatography Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- -1 diethylaminoethyl residues Chemical group 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical group CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 4
- 208000002109 Argyria Diseases 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 229940123237 Taxane Drugs 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 238000005571 anion exchange chromatography Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000287 crude extract Substances 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000004114 suspension culture Methods 0.000 description 4
- 229930184023 10-desacetyltaxuyunnanin Natural products 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241001116498 Taxus baccata Species 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000012149 elution buffer Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- TYLVGQKNNUHXIP-MHHARFCSSA-N 10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)C=4C=CC=CC=4)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 TYLVGQKNNUHXIP-MHHARFCSSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241001116500 Taxus Species 0.000 description 2
- 235000009065 Taxus cuspidata Nutrition 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011098 chromatofocusing Methods 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000013580 millipore water Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 1
- YWLXLRUDGLRYDR-SKXCCXORSA-N 10-dab iii Chemical compound O([C@H]1C2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-SKXCCXORSA-N 0.000 description 1
- YWLXLRUDGLRYDR-UHFFFAOYSA-N 10-deacetylbaccatin Chemical compound CC(=O)OC12COC1CC(O)C(C(C(O)C1=C(C)C(O)CC3(O)C1(C)C)=O)(C)C2C3OC(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- YPTPYQSAVGGMFN-KQYNXXCUSA-N [(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methyl phosphono hydrogen phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1OP(O)(O)=O YPTPYQSAVGGMFN-KQYNXXCUSA-N 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 108010087926 acetyl coenzyme A - 10-hydroxytaxane O-acetyltransferase Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000719 anti-leukaemic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- YKCWQPZFAFZLBI-UHFFFAOYSA-N cibacron blue Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S(O)(=O)=O)C=C1NC(C=C1S(O)(=O)=O)=CC=C1NC(N=1)=NC(Cl)=NC=1NC1=CC=CC=C1S(O)(=O)=O YKCWQPZFAFZLBI-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 1
- 238000013365 molecular weight analysis method Methods 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Compounds Of Unknown Constitution (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19804815A DE19804815C1 (de) | 1998-02-06 | 1998-02-06 | Verfahren zur Herstellung von Baccatin |
PCT/EP1999/000599 WO1999040216A1 (fr) | 1998-02-06 | 1999-01-29 | Procede de preparation de baccatine |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20003787L NO20003787L (no) | 2000-07-24 |
NO20003787D0 NO20003787D0 (no) | 2000-07-24 |
NO320104B1 true NO320104B1 (no) | 2005-10-24 |
Family
ID=7856891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003787A NO320104B1 (no) | 1998-02-06 | 2000-07-24 | Fremgangsmate for fremstilling av baccatin i naervaere av et enzym og en acetyldonor, enzymet, fremgangsmate for fremstilling av dette og fremgangsmate for fremstilling av taxol og/eller taxolderivater. |
Country Status (20)
Country | Link |
---|---|
US (1) | US6514732B1 (fr) |
EP (1) | EP1053345B1 (fr) |
JP (1) | JP4278864B2 (fr) |
KR (1) | KR100575488B1 (fr) |
CN (1) | CN1226416C (fr) |
AT (1) | ATE260985T1 (fr) |
AU (1) | AU760122B2 (fr) |
CA (1) | CA2319136C (fr) |
CZ (1) | CZ300009B6 (fr) |
DE (2) | DE19804815C1 (fr) |
DK (1) | DK1053345T3 (fr) |
ES (1) | ES2217777T3 (fr) |
HU (1) | HU228677B1 (fr) |
NO (1) | NO320104B1 (fr) |
PL (1) | PL197703B1 (fr) |
PT (1) | PT1053345E (fr) |
RU (1) | RU2219242C2 (fr) |
SI (1) | SI1053345T1 (fr) |
SK (1) | SK284676B6 (fr) |
WO (1) | WO1999040216A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6287835B1 (en) | 1999-09-30 | 2001-09-11 | Washington State University Research Foundation | Transacylases of the paclitaxel biosynthetic pathway |
DE10013942B4 (de) * | 2000-03-21 | 2010-01-14 | Air Liquide Deutschland Gmbh | Verfahren zum Herstellen von Arzneimitteln aus Ausgangsstoffen der traditionellen chinesischen Medizin |
US20080053911A1 (en) * | 2006-08-30 | 2008-03-06 | Qiagen Gmbh | Separation of an organic phase from a mixture comprising organic and aqueous phases by solid phase systems |
CN103808850A (zh) * | 2012-11-15 | 2014-05-21 | 刘胜远 | 一种红豆杉中10-去乙酰基巴卡亭ⅲ的薄层色谱检测方法 |
CN103808853A (zh) * | 2012-11-15 | 2014-05-21 | 刘胜远 | 一种红豆杉中7-木糖-10-去乙酰基紫杉醇的薄层色谱检测方法 |
CN103808854A (zh) * | 2012-11-15 | 2014-05-21 | 刘胜远 | 一种红豆杉中巴卡亭ⅲ的薄层色谱检测方法 |
CN103808851A (zh) * | 2012-11-15 | 2014-05-21 | 刘胜远 | 一种红豆杉中10-去乙酰基紫杉醇的薄层色谱检测方法 |
-
1998
- 1998-02-06 DE DE19804815A patent/DE19804815C1/de not_active Expired - Fee Related
-
1999
- 1999-01-29 KR KR1020007008519A patent/KR100575488B1/ko not_active IP Right Cessation
- 1999-01-29 AT AT99934214T patent/ATE260985T1/de active
- 1999-01-29 CZ CZ20002723A patent/CZ300009B6/cs not_active IP Right Cessation
- 1999-01-29 WO PCT/EP1999/000599 patent/WO1999040216A1/fr active IP Right Grant
- 1999-01-29 ES ES99934214T patent/ES2217777T3/es not_active Expired - Lifetime
- 1999-01-29 JP JP2000530627A patent/JP4278864B2/ja not_active Expired - Lifetime
- 1999-01-29 EP EP99934214A patent/EP1053345B1/fr not_active Expired - Lifetime
- 1999-01-29 AU AU32519/99A patent/AU760122B2/en not_active Ceased
- 1999-01-29 DE DE59908741T patent/DE59908741D1/de not_active Expired - Lifetime
- 1999-01-29 SI SI9930568T patent/SI1053345T1/xx unknown
- 1999-01-29 SK SK1124-2000A patent/SK284676B6/sk not_active IP Right Cessation
- 1999-01-29 RU RU2000123174/13A patent/RU2219242C2/ru not_active IP Right Cessation
- 1999-01-29 CA CA002319136A patent/CA2319136C/fr not_active Expired - Fee Related
- 1999-01-29 CN CNB998027057A patent/CN1226416C/zh not_active Expired - Fee Related
- 1999-01-29 US US09/582,223 patent/US6514732B1/en not_active Expired - Lifetime
- 1999-01-29 PL PL342711A patent/PL197703B1/pl unknown
- 1999-01-29 HU HU0100724A patent/HU228677B1/hu not_active IP Right Cessation
- 1999-01-29 DK DK99934214T patent/DK1053345T3/da active
- 1999-01-29 PT PT99934214T patent/PT1053345E/pt unknown
-
2000
- 2000-07-24 NO NO20003787A patent/NO320104B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1053345A1 (fr) | 2000-11-22 |
EP1053345B1 (fr) | 2004-03-03 |
ES2217777T3 (es) | 2004-11-01 |
AU3251999A (en) | 1999-08-23 |
KR20010040647A (ko) | 2001-05-15 |
KR100575488B1 (ko) | 2006-05-03 |
DK1053345T3 (da) | 2004-06-21 |
US6514732B1 (en) | 2003-02-04 |
DE19804815C1 (de) | 1999-04-15 |
DE59908741D1 (de) | 2004-04-08 |
ATE260985T1 (de) | 2004-03-15 |
NO20003787L (no) | 2000-07-24 |
CZ300009B6 (cs) | 2009-01-14 |
PL197703B1 (pl) | 2008-04-30 |
HU228677B1 (en) | 2013-05-28 |
NO20003787D0 (no) | 2000-07-24 |
JP2002502613A (ja) | 2002-01-29 |
PT1053345E (pt) | 2004-07-30 |
SI1053345T1 (en) | 2004-08-31 |
CA2319136A1 (fr) | 1999-08-12 |
CN1290305A (zh) | 2001-04-04 |
CZ20002723A3 (cs) | 2001-01-17 |
SK284676B6 (sk) | 2005-09-08 |
HUP0100724A3 (en) | 2002-04-29 |
RU2219242C2 (ru) | 2003-12-20 |
JP4278864B2 (ja) | 2009-06-17 |
CN1226416C (zh) | 2005-11-09 |
AU760122B2 (en) | 2003-05-08 |
HUP0100724A2 (hu) | 2001-12-28 |
WO1999040216A1 (fr) | 1999-08-12 |
CA2319136C (fr) | 2008-09-09 |
PL342711A1 (en) | 2001-07-02 |
SK11242000A3 (sk) | 2001-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Levac et al. | Application of carborundum abrasion for investigating the leaf epidermis: molecular cloning of Catharanthus roseus 16‐hydroxytabersonine‐16‐O‐methyltransferase | |
Ritala et al. | Evaluation of tobacco (Nicotiana tabacum L. cv. Petit Havana SR1) hairy roots for the production of geraniol, the first committed step in terpenoid indole alkaloid pathway | |
Sanchez et al. | Changes in peroxidase activity associated with cell walls during pine hypocotyl growth | |
JP6159737B2 (ja) | 分離方法における、フィブリルセルロースを含む固定相の使用 | |
EP0531639B1 (fr) | Tocophérol cyclase | |
Marques et al. | Elicitor-induced L-tyrosine decarboxylase from plant cell suspension cultures: I. Induction and purification | |
NO320104B1 (no) | Fremgangsmate for fremstilling av baccatin i naervaere av et enzym og en acetyldonor, enzymet, fremgangsmate for fremstilling av dette og fremgangsmate for fremstilling av taxol og/eller taxolderivater. | |
Gerasimenko et al. | Development of an efficient system for the separation of indole alkaloids by high performance liquid chromatography and its applications | |
Menhard et al. | Special publication Purification and characterization of acetyl coenzyme a: 10-hydroxytaxane O-acetyltransferase from cell suspension cultures of Taxus chinensis | |
Srivastava et al. | Interactions among phenolics and peroxidase isozymes | |
Linskens | Activation of the ovary | |
CN115433747A (zh) | 葛根素6′′-o-乙酸酯的酶促合成方法 | |
CN104428308B (zh) | 环状大环内酯类化合物的分离方法 | |
CN114230681A (zh) | 一种胞外多糖提取物、胞外多糖及其应用 | |
He et al. | A novel lipase-based stationary phase in liquid chromatography | |
JP3916144B2 (ja) | 微生物によるジャスモン酸類及びセオブロキシドの製造方法 | |
Delattre et al. | Purification of oligouronides by immobilized L-histidine pseudoaffinity chromatography | |
Kwon et al. | Chiral separation and discrimination of catechin by microbial cyclic beta-(1→ 3),(1→ 6)-glucans Isolated from bradyrhizobium japonicum | |
CN108570491B (zh) | 一种微生物谷氨酰胺转胺酶稳定性的检测方法 | |
JP2006288303A (ja) | リボフラビン配糖体の精製方法および分析方法 | |
Vovk et al. | Separation of pectin methylesterases and polygalacturonases on monolithic columns | |
Schütte et al. | Isolation techniques | |
JPS58101684A (ja) | けい藻類の増殖方法 | |
CN114088898A (zh) | 一种制备药物代谢酶-多孔材料复合物的方法及应用 | |
CN118272389A (zh) | 一种与芡实儿茶素合成相关的转录因子EfMYB5b基因及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |